What is Integrated Tissue Dynamics?
Integrated Tissue Dynamics (INTiDYN) operates as a pivotal biomedical research partner, focused on translating complex molecular and cellular discoveries into tangible therapeutic options. The company leverages its proprietary ChemoMorphometric Analysis (ITD-CMA) platform to streamline the progression from fundamental research to clinical application. INTiDYN provides clients, including major pharmaceutical firms and research institutions, with immediate access to a high-quality tissue reserve, thereby accelerating new discoveries and enhancing research project efficiency and effectiveness.
How much funding has Integrated Tissue Dynamics raised?
Integrated Tissue Dynamics has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
Key Investors in Integrated Tissue Dynamics
PPP
Public-Private Partnership
What's next for Integrated Tissue Dynamics?
With significant Series B/C stage backing, Integrated Tissue Dynamics is poised for accelerated growth and enhanced market penetration. The recent capital infusion is expected to fuel further development of its ITD-CMA platform and expand its service offerings to a broader client base. This strategic investment will likely enable INTiDYN to solidify its role as a key enabler of therapeutic innovation, bridging the gap between early-stage discovery and clinical viability.
See full Integrated Tissue Dynamics company page
